Welcome Cure, a pioneering figure in the homeopathy technology sector, has recently announced a successful acquisition of over 4 Crores in a Pre-series A funding round. This round was prominently led by Inflection Point Ventures (IPV). The funds are allocated to amplify operations, refine technological facets, drive talent acquisition, and bolster marketing campaigns. The healthcare trailblazer has set its sights on a sum exceeding 16 crores in this ongoing fundraising initiative.
Aiming to fill the gap in sustainable and holistic healthcare, Welcome Cure extends a unified approach in the widely scattered homeopathy market. Their services span both online and offline channels, concentrating on comprehensive healthcare aspects from diagnosis and treatment to prevention and overall health enhancement.
The leadership compass of Welcome Cure is steered by seasoned professionals like Dr. Jawahar Shah, an MD in Homeopathy with a vast clinical experience spanning 45 years. Complementing his vision are co-founders Punit Desai, serving as the CEO, and Nidhi Desai, the COO. Their entrepreneurial acumen ensures that Welcome Cure remains at the forefront of holistic healthcare innovations.
Inflection Point Ventures’ partner, Vikram Ramasubramanian, shed light on the growing global resonance of Homeopathy, especially its prowess in addressing chronic ailments. He lauded Welcome Cure’s distinct approach that has reshaped the way patients interact with doctors, ensuring all-encompassing care. IPV is committed to catalyzing Welcome Cure’s upward trajectory.
Garnering attention with a vast user base of over 2.5 million and 1.5 million registered patients across 36 countries, Welcome Cure’s outreach is indeed expansive. Their software suite is also adopted by 1 lakh doctors from over 140 countries. Their crown jewel, however, is the integration of proprietary Assisted Intelligence (AI) solutions. This technological marvel significantly augments physicians’ decision-making capabilities, enhancing patient care standards across diagnostics, treatment methodologies, and consistent monitoring.
Expressing his aspirations, Dr. Shah envisions Welcome Cure emerging as the primary choice in the homeopathy realm. This sentiment finds roots in the widespread acceptance and potential of homeopathy, a vision further amplified with IPV’s strategic partnership.
Despite being in its nascent stages, Welcome Cure has showcased remarkable organic growth. Positive financial returns for two consecutive years and a business accumulation of over 45+ crores highlight its stronghold in the alternative medicine landscape. Their efforts haven’t gone unnoticed, with accolades from esteemed dignitaries including Prime Minister Narendra Modi and other illustrious organizations.
Current valuations place the homeopathy sector at an impressive 7 billion USD, with a promising growth trajectory of 18% CAGR. Industry experts predict a surge, potentially crossing the 21 billion USD mark within the next half-decade.
About Welcome Cure:
Marking its presence as an innovative Homeopathy Technology firm, Welcome Cure offers an AI-integrated solution tailored for physicians. Their global footprint extends holistic care to patients via the Tele-medicine Platform, having already catered to 2.5 million+ patients across 36+ nations.
About Inflection Point Ventures & Physis Capital:
Renowned as a significant angel investing platform, IPV boasts a vast network of over 8600 professionals, championing the cause of budding entrepreneurs by equipping them with essential resources. Their recent venture includes the launch of the $50 million CAT 2 AIF Physis Capital, targeting startups from the pre-Series A to Series B stages.
